Did RSV vaccine clinical trials end abruptly for safety concerns?
The tweet falsely claims that all RSV vaccine trials by GSK were abruptly ended due to safety concerns; in reality, only one trial was paused for safety analysis, and the rest are ongoing, with no single RSV vaccine being the focus of all concerns.